Abstract
First reports on the presence of pharmaceuticals in the environment were published in the early 1970s, but it was not until better analytical instruments became available that scientists began to develop a real interest in the topic. When in the 1990s concerns began to grow about the presence of pharmaceuticals in drinking water, the subject also aroused increased interest among the general public. Since then, pharmaceuticals in the environment have continued to be a “hot bed” of interest, as demonstrated by the huge number of publications (for an overview see the book “Pharmaceuticals in the Environment. Sources, fate effects and Risk”, Springer Publisher).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anastas P (2008) Fusing green chemistry and green engineering: DesignBuild at the molecular level. Green Chem 10, 607
Anastas PT, Warner JC (1998) Green Chemistry: Theory and Practice. Oxford University Press, Oxford
Clark JH (2006) Green chemistry: Today (and tomorrow). Green Chem 8, 17–21
Clark JH, Smith P (2005) Basic principles of green chemistry. Innov Pharm Technol 16, 94–97
Daughton CG (2003) Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. Rationale for and avenues toward a green pharmacy. Environ Health Persp 111, 757–774
Ekins S (ed.) (2007) Computational Toxicology: Risk Assessment for Pharmaceutical and Environmental Chemicals. John Wiley and Sons, Hoboken
EU Parliament and EU-Commission (2002), Beschluss Nr. 1600/2002/EG des Europäischen Parlaments und des Rates vom 22. Juli 2002 über das sechste Umweltaktionsprogramm der Europäischen Gemeinschaft, 10.9.2002, Amtsblatt der Europäischen Gemeinschaften, L 242/1–15, 2002. 24
German Advisory Board for Environment (2003) Der Rat von Sachverständigen für Umweltfragen. Zur Wirtschaftsverträglichkeit der Reform der Europäischen Chemikalienpolitik. Stellungnahme Nr. 4, Juli, S. 29, Ziffer 38, 2003.
Hofmeister S, Kümmerer K (2009) Sustainability, substance flow management and time. Part II: Temporal impact assessment (TIA) as a new versatile tool for sustainable substance flow management. J Environ Manage 90, 1377–1384
Jones OH, Green PG, Voulvoulis N, Lester JN (2007) Questioning the excessive use of advanced treatment to remove organic micro-pollutants from waste water. Environ Sci Technol 41,5085–5089
Kümmerer K (2007) Sustainable from the very beginning: rational design of molecules by life cycle engineering as an important approach for green pharmacy and green chemistry. Green Chem 9, 899–907
Kümmerer K (ed.) (2008a) Pharmaceuticals in the Environment. Sources, Fate, Effects and Risks. 3rd edition, Springer Publisher, Berlin Heidelberg New York
Kümmerer K (2008b) Strategies for reducing the input of pharmaceuticals into the environment. In: Kümmerer K (ed.) Pharmaceuticals in the Environment. Sources, Fate, Effects and Risks. 3rd edition, Springer Publisher, Berlin Heidelberg New York, 433–440
Kümmerer K, Hofmeister S (2008) Sustainability, substance flow management and time. Part I Temporal analysis of substance flows. J Environ Manage 88, 1333–1342
Kümmerer K, Velo GP (2006) Ecopharmacology: a new topic of importance in pharmacovigilance. Drug Safety 29, 371–373
Lapkin A, Constable D (2009) Green Chemistry Metrics: Measuring and Monitoring Sustainable Processes. Wiley, Chichester
Larsson DG, de Pedro C, Paxeus N (2007) Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J Hazard Mater 148, 751–755
Li D, Yang M, Hu J, Ren L, Zhang Y, Chang H, Li K (2008a) Determination and fate of oxytetracycline and related compounds in oxyteracycline production wastewater and the receiving river. Environ Tox Chem 27, 80–86
Li D, Yang M, Hu J, Zhang Y, Chang H, Jin F (2008b) Determination of penicillin G and its degradation products in a penicillin production wastewater treatment plant and the receiving river. Water Res 42, 307–317
Sheldon RA (1992) Organic synthesis – past, present and future. Chem Ind-London, 903–906
Sheldon RA (2007) The E factor: fifteen years on. Green Chem 9, 1273–1283
Wenzel H, Larsen HF, Clauson-Kaas J, Høibye L, Jacobsen BN (2008) Weighing environmental advantages and disadvantages of advanced wastewater treatment of micro-pollutants using environmental life cycle assessment. Water Sci Technol 57, 27–32
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kümmerer, K. (2010). Why Green and Sustainable Pharmacy?. In: Kümmerer, K., Hempel, M. (eds) Green and Sustainable Pharmacy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-05199-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-05199-9_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-05198-2
Online ISBN: 978-3-642-05199-9
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)